Chinese Molecular Diagnostic Start-Up Closes $14M Series Pre-A Round

Singleron Biotechnologies, a Chinese biotechnology start-up providing molecular diagnostic services, announced on Friday that it has raised nearly RMB100 million (US$14.57 million) in a series pre-A round of financing led by Beijing-based Sherpa Venture Capital.

China Money Network

Subscribe & Access the Best Data and Intelligence on Chinese Venture Capital and Tech

Register Now

Want to read this important story?

Access thousands of news articles and data posts over the past 9 years!

Already have an account or paid subscription? Log in

Caishen.Co - Primary Data for China Secondary Investment and Stock Markets